Saturday, May 16, 2009

Racial/Socioeconomic factors predictors to admission in high-quality pituitary centers

3 responses
"The prevalence of clinically significant pituitary tumors has been reported to be as high as 94 +/- 19.3 cases per 100,000 population."

The authors of this study, done at the Johns Hopkins School of Medicine, reviewed a number of reports which "suggest that patients with surgical pituitary disease are much more likely to have improved surgical outcomes if diagnosed and treated by more experienced surgeons..." They looked at a national survey of neurosurgeons done in the U.S. and a similar study published in the U.K., both of which "found that complication rates were inversely related to surgical experience".

These studies showed patients undergoing the preferred method of pituitary adenoma removal, transsphenoidal resection, had lower mortality rates and less complications if admitted to "high-volume centers".

Referring to "recent reports in general surgery" which "indicate that referral to high-volume hospitals is dependent on racial and socioeconomic factors", the authors realized that little is known about the same possible disparity with the aforementioned pituitary surgery patients.

Using the data from 1988-2005 found in the National Inpatient Sample (NIS) in-hospital discharge database, they identified the pituitary tumor patients by operative code (vs. diagnostic code) for its "higher fidelity". Then, socioeconomic and environmental factors were "assessed through Area Resource File (ARF), maintained by the Health Resources and Services Administration". Only patients over 18 years of age were identified, and only those meeting the criteria of codes were included.

Centers which did over 25 pituitary surgeries per year were defined as "high-volume centers". Age, gender, race, income, wealth, insurance status and the Charlson comorbidity index score were variables used to delineate the racial and socioeconomic factors.

"There was no statistically significant difference between African-Americans (OR: 0.86, 95% CI: 0.74-1.00) and whites in access to high-volume centers (Table 3). On the other hand, Hispanic (OR: 0.53, 95% CI: 0.45-0.63) and Asian (OR: 0.78, 95% CI: 0.61-0.98) patients were significantly less likely to be seen at high-volume centers."

However, when using only the last five years (2001-2005), there was a significantly greater chance that Caucasians would admitted to high volume centers.

In this study, they also found "patients from counties with high neurosurgeon density experience a greater chance of admission to quality medical centers". Younger patients were more likely to be admitted to these same centers as compared to older patients. This was partially attributed to a "widespread access to internet in younger patients".

Females were also more likely to be admitted to high-volume centers than males. Since women are more likely to be uninsured and have less healthcare than men according to the authors, this was surprising. They surmised the need to preserve pituitary and hormonal function in women may have an active role.

What I found more telling, but only mentioned briefly, was how skewed the numbers were for those who were referred anywhere. The number of patients receiving care in the >$60,000/yr income-bracket was almost double the other income levels. In fact, the other income levels were very close.

The authors conclude: "This study demonstrates potential key policy areas for meaningful intervention to help ease disparities in access to quality care for surgical pituitary disease."


Mukherjee, D., Zaidi, H., Kosztowski, T., Chaichana, K., Salvatori, R., Chang, D., & Quinones-Hinojosa, A. (2009). Predictors of Access to Pituitary Tumor Resection in the United States, 1988-2005 European Journal of Endocrinology DOI: 10.1530/EJE-09-0043

Wednesday, May 13, 2009

Reporter Tweets Removal of Pituitary Adenoma

0 responses
A couple of weeks ago I blogged about the reporter who tweeted during a surgery to remove a pituitary adenoma, the cause of Cushing's Disease. Last night, her station ran a segment on the event and posted an article complete with uploaded video. Thanks to KSDK and Kay Quinn, the video may be viewed at their site or below:




To read more: St. Louis medical milestone: Twittering from Barnes-Jewish Hospital operating room

Sunday, May 10, 2009

Vitamin D deficiency is associated with increased mortality

4 responses
A recent letter published in the New England Journal of Medicine emphasized the importance of treating Vitamin D deficiency in acute as well as chronic illness. Dr. Paul Lee and others followed a group of 42 patients in the ICU of St. Vincent's Hospital in Sydney, Australia over the course of a year.

When testing the "serum level of 25-hydroxyvitamin D" in 42 "referred patients", the mean was 41±22 nmol per liter (16±9 ng per milliliter). 45% were deficient in Vitamin D. The Simplified Acute Physiology Score II (SAPS II) "in patients with sufficient, insufficient, and deficient levels of vitamin D were 34±11, 45±13, and 51±13, with predicted mortality rates of 16%, 35%, and 45%, respectively."

The current study involving patients in the ICU reveals a high prevalence of hypovitaminosis D that was associated with adverse outcomes, independently of hypocalcemia and hypoalbuminemia.

Vitamin D deficiency is associated with increased mortality. This study cannot establish causality between hypovitaminosis D and adverse outcomes.

In a press release, Dr. Lee said, "There may be a bias, in that all patients were referred to endocrinology, so the numbers may not reflect the prevalence in a standard ICU cohort. However 45% is still a significant proportion. ...when we are very sick, the "sick organs" draw upon any vitamin D available to function properly, therefore we may need extra Vitamin D to maintain organ function during critical illness. However, at this stage, we don't know whether Vitamin D deficiency is just a marker of ill health, or whether it contributes to disease severity."



Lee p, Eisman JA, Center JR (2009). Vitamin D Deficiency i Critically Ill Patient New England Journal of Medicine, 360 PMID: 19403914

Sunday, May 3, 2009

Adult Onset Growth Hormone Deficiency: Phenotype and Benefits of Treatment

2 responses
Growth Hormone Replacement Therapy in Adult Onset Growth Hormone Deficiency Induces Favourable Long-Term Effects: Presented at ECE

"Long-term, near-physiological replacement of growth hormone (GH) has favourable effects on bone, quality of life, and various metabolic factors in patients with severe adult-onset growth hormone deficiency (GHD), according to a prospective, open follow-up study presented...on April 28 at the 11th European Congress of Endocrinology (ECE)." (click title to read full article)

Untreated Growth Hormone Deficiency Contributes to the Phenotype of Patients With History of Cushing's Disease: Presented at ECE

"Untreated growth hormone deficiency (GHD) may contribute to the phenotype of patients with a history of Cushing's disease (CD), according to a prospective cohort study presented here on April 28 at the 11th European Congress of Endocrinology (ECE)..." (click title to read full article)

Tags

101 (6) 2009 (1) ACTH (3) addison's (2) adenoma (10) adrenal (6) adrenal adenomas (2) adrenal insufficiency (8) adrenalectomy (1) androgens (2) anger (1) animals (1) antibiotic (1) apathy (1) apnea (1) arginine (1) attitude (2) awareness (19) bacteria (1) bariatric (4) bilateral adrenalectomy; zebra (2) BLA (6) blog carnival (1) blogging (1) blogtalkradio (1) blood work (1) buffalo hump (1) cancer (1) carcinoma (1) cardiovascular (2) change (1) chronic (1) chronic illness (8) circadian (2) classical (1) cold (2) conn's (1) cortef (1) corticosteriod (2) cortisol (7) CSF (1) CT scan (1) cure (1) cushing (1) cushing's (77) cyberchondriac (2) cyclic (2) data (1) database (1) death (4) depression (1) dexamethasone (1) diabetes (3) diabetes insipidus (1) diagnose (1) diagnosis (10) disease (1) diurnal (2) doctor (3) doctor blogs (21) doctor friedman (1) doctors (2) doctors google (1) drugs (2) dynamic MRI (2) ectopic (2) education (1) EHR (1) EMR (1) endocrine (5) endocrinology (1) epatients (5) epigenetics (4) epinephrine (1) episodic (2) estrogen (1) familial (2) fat (1) fatigue (1) ferritin (2) florid (1) flu (1) fluid control (1) food (1) gadolinium (2) galactorrhea (1) gamma knife (3) genetics (3) genotropin (1) gland (1) google (1) google health (1) googling (2) grand rounds (4) growth hormone (13) guest post (1) headache (2) health care system (14) health records (4) healthcare (1) HIPAA (1) hirsutism (1) holiday (4) home (1) hoofbeats (1) hormone (1) hormones (5) hormones bioidentical (1) HRT (1) hurt (1) hypercortisolism (1) hyperplasia (1) hypertension (1) hyperthyroidism (2) hypoparathyroidism (1) hypopitiutarism (4) hypothalamus (2) hypothyroidism (7) iatrogenic (1) ice crunching (1) illness (3) imaging (4) immune (1) immunocompromised (1) infection (2) information (2) insurance (2) internet (1) invisible illness (1) iron (1) journey (2) ketoconazole (3) kidney (1) labs (2) lapband (1) laproscopic (1) levaquin (2) libido (1) macroadenoma (2) medical records (2) medical school (1) men (1) metabolic syndrome (3) metamorphosis (1) microadenoma (1) microscopy (1) mild (1) morbidity (2) mortality (1) MRI (2) MRSA (1) mucinex (1) neuroblastoma (1) news (10) night owl (1) nodules (1) norepinephrine (1) obesity (13) obesity hunger willpower (2) Occam's Blade (1) OFM (1) osteoporosis (2) pain (4) parathyroid (3) participatory medicine (2) pasireotide (1) patient rights (2) patients (7) patientsfirst (1) PCOS (6) PCP (1) pediatric (2) peer reviewed (1) percocet (1) personal (1) PET (1) phenotype (1) pheochromoctyoma (1) pheochromocytoma (1) PHR (3) pictures (1) pituitary (24) pituitary surgery (7) pituitary tumor adenoma research acromegaly (1) poll (1) polycystic (2) prolactinoma (1) protein (1) psychological (1) radiation (1) radio; cushing's (2) rant (1) recurrence (1) reform (2) relationships (1) remission (2) research (26) respect (1) retrospective (4) rocephin (1) safari (1) salivary (2) sarcoidosis (1) science (1) serum cortisol (1) shame (1) sick (1) sinus (1) sinus infection (2) sinusitis (1) sleep (2) soda (1) spoon theory (1) steriod (1) steroids (1) subclinical (2) surgery (11) surgeXperiences (2) survival (1) symptom (1) technology (1) temozolomide (1) testing (6) testosterone (2) thyroid (6) to google (1) top10 (1) transsphenoidal endoscopic (1) travel (2) treatment (3) trust (1) tumor (12) twitter (5) urinary free cortisol (2) urinary infection (2) UTI (1) veteran (1) video (3) Vitamin D (6) weakness (1) zebra (5) zippy (1)

Email me....

survivethejourney at gmail dot com

Subscribe via email

Enter your email address:

Delivered by FeedBurner